Catia Traversari
Catia Traversari
Unknown affiliation
Verified email at
TitleCited byYear
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.
P van der Bruggen, C Traversari, P Chomez, C Lurquin, E De Plaen, ...
Science (New York, NY) 254 (5038), 1643, 1991
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia
C Bonini, G Ferrari, S Verzeletti, P Servida, E Zappone, L Ruggieri, ...
Science 276 (5319), 1719-1724, 1997
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
PG Coulie, V Brichard, A Van Pel, T Wölfel, J Schneider, C Traversari, ...
Journal of Experimental Medicine 180 (1), 35-42, 1994
Structure, chromosomal localization, and expression of 12 genes of the MAGE family
E De Plaen, C Traversari, JJ Gaforio, JP Szikora, C De Smet, F Brasseur, ...
Immunogenetics 40 (5), 360-369, 1994
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
C Traversari, P van der Bruggen, IF Luescher, C Lurquin, P Chomez, ...
Journal of Experimental Medicine 176 (5), 1453-1457, 1992
Differentiation of T regulatory cells by immature dendritic cells
MG Roncarolo, MK Levings, C Traversari
Journal of Experimental Medicine 193 (2), F5-F10, 2001
HMGB1 is an endogenous immune adjuvant released by necrotic cells
P Rovere‐Querini, A Capobianco, P Scaffidi, B Valentinis, F Catalanotti, ...
EMBO reports 5 (8), 825-830, 2004
A peptide encoded by human gene MAGE‐3 and presented by HLA‐A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE‐3
P van der Bruggen, J Bastin, T Gajewski, PG Coulie, P Boël, C De Smet, ...
European journal of immunology 24 (12), 3038-3043, 2005
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase …
F Ciceri, C Bonini, MTL Stanghellini, A Bondanza, C Traversari, ...
The lancet oncology 10 (5), 489-500, 2009
Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer
F Mavilio, G Ferrari, S Rossini, N Nobili, C Bonini, G Casorati, ...
Blood 83 (7), 1988-1997, 1994
Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes
C Traversari, P Bruggen, B Eynde, P Hainaut, C Lemoine, N Ohta, L Old, ...
Immunogenetics 35 (3), 145-152, 1992
Rexpression of HLA class I antigens and restoration of antigen‐specific CTL response in melanoma cells following 5‐aza‐2′‐deoxycytidine treatment
A Serrano, S Tanzarella, I Lionello, R Mendez, C Traversari, ...
International journal of cancer 94 (2), 243-251, 2001
A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease
DC Thomis, S Marktel, C Bonini, C Traversari, M Gilman, C Bordignon, ...
Blood 97 (5), 1249-1257, 2001
Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses
EJ Villablanca, L Raccosta, D Zhou, R Fontana, D Maggioni, A Negro, ...
Nature medicine 16 (1), 98, 2010
Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors
S Verzeletti, C Bonini, S Marktel, N Nobili, F Ciceri, C Traversari, ...
Human gene therapy 9 (15), 2243-2251, 1998
Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2′-deoxycytidine
L Sigalotti, E Fratta, S Coral, S Tanzarella, R Danielli, F Colizzi, E Fonsatti, ...
Cancer research 64 (24), 9167-9171, 2004
The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic …
C Traversari, S Marktel, Z Magnani, P Mangia, V Russo, F Ciceri, C Bonini, ...
Blood 109 (11), 4708-4715, 2007
Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1
P Chaux, R Luiten, N Demotte, V Vantomme, V Stroobant, C Traversari, ...
The Journal of Immunology 163 (5), 2928-2936, 1999
Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response
V Russo, S Tanzarella, P Dalerba, D Rigatti, P Rovere, A Villa, ...
Proceedings of the National Academy of Sciences 97 (5), 2185-2190, 2000
Antitumor effects of HSV-TK–engineered donor lymphocytes after allogeneic stem-cell transplantation
F Ciceri, C Bonini, S Marktel, E Zappone, P Servida, M Bernardi, ...
Blood 109 (11), 4698-4707, 2007
The system can't perform the operation now. Try again later.
Articles 1–20